OCTREOTIDE ACETATE - Food and Drug Administration

Set ID
8f3fde6c-976e-4e4c-8ed4-542294fcc0ef
Type
Indexing - product concept
Effective date
2021-01-15
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameSagent Pharmaceuticals2026-09-20
These highlights do not include all the information needed to use SANDOSTATIN INJECTION safely and effectively. See full prescribing information for SANDOSTATIN INJECTION. SANDOSTATIN ® (octreotide acetate) INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameNovartis Pharmaceuticals Corporation2026-07-22
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameGLENMARK PHARMACEUTICALS INC., USA | Gland Pharma Limited2026-01-30
These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION. OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988Product nameMylan Institutional LLC2026-01-21
These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION. OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988Product nameMylan Institutional LLC2026-01-21
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameHikma Pharmaceuticals USA Inc.2026-01-13
These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988Product nameNovartis Pharmaceuticals Corporation2025-12-22
These highlights do not include all the information needed to use SANDOSTATIN INJECTION safely and effectively. See full prescribing information for SANDOSTATIN INJECTION. SANDOSTATIN ® (octreotide acetate) INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameNovartis Pharmaceuticals Corporation2025-08-11
These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988Product nameNovartis Pharmaceuticals Corporation2025-08-11
These highlights do not include all the information needed to use MYCAPSSA ® safely and effectively. See full prescribing information for MYCAPSSA. MYCAPSSA (octreotide) delayed-release capsules, for oral use Initial U.S. Approval: 1988Product nameChiesi USA, Inc. | Almac Pharma Services Limited | Assia Chemical Industries Ltd. - Teva Tech Site | Lyophilization Services of New England, Inc. (LSNE) | MW ENCAP LIMITED | Novetide Ltd.2025-07-24
These highlights do not include all the information needed to use MYCAPSSA ® safely and effectively. See full prescribing information for MYCAPSSA. MYCAPSSA (octreotide) delayed-release capsules, for oral use Initial U.S. Approval: 1988Product nameAmryt Pharmaceuticals Designated Activity Company | Almac Pharma Services Limited | Assia Chemical Industries Ltd - Teva Tech Site | Lyophilization Services of New England, Inc. (LSNE) | MW ENCAP LIMITED | Novetide Ltd.2025-07-24
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameSagent Pharmaceuticals2025-07-01
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameHainan Shuangcheng Pharmaceuticals Co., Ltd.2025-06-25
These highlights do not include all the information needed to use BYNFEZIA PEN safely and effectively. See full prescribing information for BYNFEZIA PEN. BYNFEZIA PEN ® (octreotide acetate) injection, for subcutaneous use Initial U.S. Approval: 1988Product nameSun Pharmaceutical Industries, Inc. | OneSource Specialty Pharma Limited2025-02-21
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameMeitheal Pharmaceuticals, Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd2025-01-16
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | USV Private Limited2024-12-03
These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION . OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 1988Product nameTeva Pharmaceuticals, Inc.2024-07-30
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameGland Pharma Limited2024-07-29
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameGland Pharma Limited2024-07-25
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION . OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameMylan Institutional LLC2024-07-15
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameFresenius Kabi USA, LLC2024-05-23
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameFresenius Kabi USA, LLC2024-05-07
These highlights do not include all the information needed to use OCTREOTIDE ACETATE INJECTION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE INJECTION. OCTREOTIDE ACETATE injection, for subcutaneous or intravenous use Initial U.S. Approval: 1988Product nameHikma Pharmaceuticals USA Inc.2024-03-01
Octreotide Acetate Injection Rx onlyProduct nameBryant Ranch Prepack2022-04-27
Rx ONLYProduct nameUSV North America Inc. | USV Private Limited2019-01-07
Rx Only Prescribing InformationProduct nameUSV North America Inc. | USV Private Limited2018-09-21
Octreotide Acetate InjectionProduct nameWockhardt USA LLC. | Wockhardt Limited2012-10-10
Octreotide Acetate InjectionProduct nameWockhardt Limited2012-10-10